Nuhad Ibrahim Selected Research

taxane

7/2019	ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases.
5/2011	A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.
1/2009	Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer.
4/2006	Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer.
8/2005	Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nuhad Ibrahim Research Topics

Disease

22	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2003
14	Neoplasms (Cancer) 11/2021 - 03/2003
7	Brain Neoplasms (Brain Tumor) 01/2022 - 03/2016
4	Disease Progression 01/2022 - 01/2009
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2013
3	Triple Negative Breast Neoplasms 10/2020 - 11/2011
3	Pathologic Complete Response 01/2011 - 08/2005
2	Diarrhea 01/2020 - 03/2016
2	Neurologic Manifestations (Neurological Manifestations) 01/2019 - 03/2016
1	Meningeal Carcinomatosis 01/2020
1	Central Nervous System Diseases (CNS Diseases) 03/2016
1	Carcinogenesis 08/2015
1	Febrile Neutropenia 01/2011
1	Thrombocytopenia (Thrombopenia) 01/2011
1	Infections 01/2011
1	Fatigue 02/2004
1	Arthralgia (Joint Pain) 02/2004
1	Cardiotoxicity 07/2003
1	Fever (Fevers) 07/2003
1	Leukemia 03/2003

Drug/Important Bio-Agent (IBA)

5	taxaneIBA 07/2019 - 08/2005
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2011 - 02/2004
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2011 - 07/2003
4	AnthracyclinesIBA 07/2019 - 04/2006
3	Trastuzumab (Herceptin)FDA Link 01/2021 - 07/2003
3	ErbB Receptors (EGF Receptor)IBA 10/2020 - 03/2016
3	Peptides (Polypeptides)IBA 01/2020 - 01/2009
3	neratinibIBA 01/2020 - 03/2016
3	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2009
3	Fluorouracil (Carac)FDA LinkGeneric 01/2011 - 08/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 09/2006 - 02/2004
2	etirinotecan pegolIBA 01/2022 - 07/2019
2	Hormones (Hormone)IBA 10/2020 - 01/2009
2	Estrogen ReceptorsIBA 10/2020 - 05/2011
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2020
2	Capecitabine (Xeloda)FDA Link 07/2019 - 01/2019
2	human ERBB2 proteinIBA 01/2019 - 03/2016
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2011 - 07/2003
1	talimogene laherparepvecIBA 11/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	pertuzumabIBA 01/2021
1	talazoparibIBA 10/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2020
1	paclitaxel-Angiopep-2 conjugateIBA 01/2020
1	SteroidsIBA 01/2019
1	Loperamide (Imodium)FDA LinkGeneric 03/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2016
1	Epirubicin (Ellence)FDA LinkGeneric 08/2015
1	Protein Isoforms (Isoforms)IBA 08/2015
1	Cyclin EIBA 08/2015
1	dinaciclibIBA 08/2015
1	GlycopeptidesIBA 12/2012
1	AntigensIBA 12/2012
1	Indicators and Reagents (Reagents)IBA 12/2012
1	Polysaccharides (Glycans)IBA 12/2012
1	Mucin-1 (CA 15-3 Antigen)IBA 12/2012
1	GalactosyltransferasesIBA 12/2012
1	MucinsIBA 12/2012
1	EpitopesIBA 12/2012
1	Monoclonal AntibodiesIBA 12/2012
1	Dasatinib (BMS 354825)FDA Link 11/2011
1	src-Family KinasesIBA 11/2011
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2009
1	VaccinesIBA 01/2009
1	epitumomabIBA 01/2009
1	DNA VaccinesIBA 01/2009
1	CamptothecinIBA 04/2006
1	rubitecanIBA 04/2006
1	Albumin-Bound Paclitaxel FDA Link 01/2006
1	Phenobarbital (Luminal)FDA Link 08/2005
1	tariquidar (XR9576)IBA 08/2005
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2005
1	CytokinesIBA 02/2004
1	Interleukin-10 (Interleukin 10)IBA 02/2004
1	Docetaxel (Taxotere)FDA Link 07/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2003
1	Clofarabine (Clolar)FDA Link 03/2003

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 01/2022 - 02/2004
8	Therapeutics 01/2021 - 07/2003
3	Radiotherapy 01/2021 - 03/2016
2	Immunotherapy 11/2021 - 01/2009
2	Neoadjuvant Therapy 05/2011 - 01/2011
1	Craniotomy 01/2020